HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.

Abstract
Natural gossypol (GP), a polyphenolic pigment in cottonseed, is a racemic mixture of two enantiomers, (+)GP and (-)GP. Our aim was to compare the abilities of (+/-)GP, (+)GP and (-)GP to reduce proliferation of breast cancerous epithelial cells (cEC) and cancerous stromal cells (cSC). Proliferation was measured by 3H-thymidine uptake. Results showed that (+)GP had no effect on both cEC and cSC. In contrast, in both cell types, (+/-)GP and (-)GP significantly inhibited proliferation. (+/-)GP caused reductions of 15, 46 and 82% at 25, 5.0 and 7.5 microM, respectively, in cEC, and reductions of 17, 28, 39 and 56% at 2.0, 3.0, 4.0 and 5.0 microM, respectively, in cSC. (-)GP induced reductions of 33, 89 and 98% at 2.5, 5.0 and 7.5 microM, respectively, in cEC, and reductions of 29, 51, 64 and 72% at 2.0, 3.0, 4.0 and 5.0 microM, respectively, in cSC. By RT-PCR, we found that 3 microM of (+/-)GP and (-)GP decreased cyclin D1 mRNA expression in both cell types (52% and 71%, respectively, in cEC; and 47% and 71%, respectively, in cSC), and increased transforming growth factor beta (TGFbeta) mRNA expression in both cell types (93% and 130%, respectively, in cEC; and 45% and 89%, respectively, in cSC). Interestingly, (-)GP was significantly more potent than (+/-)GP. These results show that (-)GP is the major inhibitory component of (+/-)GP, (-)GP is the more potent inhibitor of cancerous breast cell growth, and the inhibitory activity of (-)GP and (+/-)GP is related to the reduction of the cell cycle regulator, cyclin D1, and the induction of the cell proliferation inhibitor, TGFbeta.
AuthorsSuling Liu, Samuel K Kulp, Yasuro Sugimoto, Jiahua Jiang, Hsiang-Lin Chang, Michael K Dowd, Peter Wan, Young C Lin
JournalAnticancer research (Anticancer Res) 2002 Jan-Feb Vol. 22 Issue 1A Pg. 33-8 ISSN: 0250-7005 [Print] Greece
PMID12017312 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Growth Inhibitors
  • RNA, Messenger
  • Transforming Growth Factor beta
  • Cyclin D1
  • Gossypol
Topics
  • Breast Neoplasms (drug therapy, genetics, metabolism, pathology)
  • Cell Division (drug effects)
  • Cyclin D1 (biosynthesis, genetics)
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Epithelial Cells (drug effects, pathology)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Gossypol (pharmacology)
  • Growth Inhibitors (pharmacology)
  • Humans
  • RNA, Messenger (biosynthesis, genetics)
  • Stereoisomerism
  • Stromal Cells (drug effects, pathology)
  • Transforming Growth Factor beta (biosynthesis, genetics)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: